The goal of this clinical trial is to compare the effects of two different healthy lifestyles on outcomes for those with bipolar disorder. The goals are to understand the acceptability of time-restricted eating and the mediterranean diet for those who are already receiving medication treatment for bipolar disorder, and to consider how these two food plans predict changes in manic symptoms, depressive symptoms, and Quality of Life. Participants will complete daily measures of eating, sleep and mood for two weeks, and then will be assigned to follow one of the two food plans for eight weeks. The investigators will measure symptoms and Quality of Life at baseline and during and after the food plan.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Acceptability
Timeframe: immediately post-treatment (10 weeks after enrollment)
Adherence to time-restricted eating
Timeframe: Average number of daily food logs showing adherence across the 8-week intervention
Adherence to Mediterranean Diet
Timeframe: Average number of food logs showing adherence at or above the median for 2 days at the mid-point of treatment (week 6) and at the end of treatment (week 10)
Mania
Timeframe: Lower YMRS at the end of intervention (10 weeks) as compared to baseline
Depression
Timeframe: Lower MADRS at the end of intervention (10 weeks) as compared to baseline
Self-rated Quality of Life (QOL)
Timeframe: Scores at 1.5-months post-intervention (16 weeks after study entry) as compared to baseline
Mania at follow-up
Timeframe: YMRS scores will be lower at 3, 6, 12 month post-intervention follow-ups as compared to baseline
Depression at follow-up
Timeframe: MADRS scores will be lower at 3, 6, 12 month post-intervention follow-ups as compared to baseline
QOL at follow-up
Timeframe: Brief QOL.BD scores will be higher at 6- and 12-month post-intervention follow-ups as compared to baseline